8IM1.F Implantica AG

Healthcare Health Care Equipment & Supplies Frankfurt Exchange
- EUR
Market cap
-
P/E
-
P/B
-
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2023.

Is 8IM1.F undervalued?

Graham number

The Graham number of Implantica AG cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Implantica AG fundamental analysis

No fundamental analysis for Implantica AG yet.

Implantica AG stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Implantica AG

Implantica AG engages in the research and distribution of medical implants in Switzerland and Spain. The company's lead product candidate is RefluxStop, a passive CE-marked implant for prevention of gastroesophageal reflux disease. It focuses on two treatment areas, Gastrointestinal surgery and Urology. It is also involved in the development of eHealth platform, a digital health system monitor, transmit, and actively treat conditions from within the body; e-InVivo, a sensor …

Full company profile